Colon Colorectal Carcinoma

Molecular Pathology of Colorectal Cancer

Harada, Shuko MD; Morlote, Diana MDAuthor Information Advances In Anatomic Pathology: January 2020 - Volume 27 - Issue 1 - p 20-26doi: 10.1097/PAP.0000000000000247

Molecular Pathology of Colorectal Cancer : Advances in Anatomic PathologyLWW

Approval of pembrolizumab (MSI- H/dMMR) and considerations for site-agnostic development of drugs in oncology

https://www.ema.europa.eu/en/documents/presentation/presentation-session-5-approval-pembrolizumab-msi-h/dmmr-considerations-site-agnostic-development-drugs-oncology-steven-lemery_en.pdf

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Colon and Rectum

https://documents.cap.org/protocols/cp-gilower-colonrectum-14biomarker-1201.pdf

NCCN Guidelines Colon Cancer

https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf

FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

https://www.fda.gov/news-events/press-announcements/fda-approves-first-line-immunotherapy-patients-msi-hdmmr-metastatic-colorectal-cancer

Lynch syndrome screening in colorectal cancer: results of a prospective 2-year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2-million population

Lynch syndrome screening in colorectal cancer: results of a prospective 2-year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2-million population

Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20

https://link.springer.com/article/10.1007/s00428-021-03260-w